Your Challenges Require Smart Solutions:
In Vitro & In Vivo Pharmacology
:format:(webp)/f/69940/1600x1000/6efac90945/gba-pharma-159334309-w1600.jpg)
In-Depth Knowledge
To gain profound and relevant preclinical data on efficacy and potency, in-depth knowledge of the corresponding disease is a key success factor. Pharmacelsus has a proven track record on conducting In Vitro and In Vivo studies on potency, selectivity and efficacy in several indication areas.
In Vitro Pharmacology Assays
5α Reductase Inhibitors
- Human Recombinant Isoenzymes Type I and II
In Vivo Pharmacology Models
Diabetes / Metabolic Syndrome Models
- Induced Models:
- STZ Mice/Rats
- DIO Mice/Rat
- Genetic Models
- ob / ob Mice
- db / db Mice
- Zucker /ZDF Rat
Cancer
- In Vivo Model (Immunodeficient Mice)
- Principle: s.c. Tumor Xenograft Model
- General Readouts: Tumor Incidence, Tumor Size, Tumor Growth Inhibition, Terminal Tumor Weight, Occurrence of Metastases (Postmortal)
Leveraging our experience allows us to design, set-up and perform In Vitro and In Vivo Pharmacology studies according to the specific requirements of your project.
Please contact us for your specific pharmacology study.
Dr. Julia Przibilla
ADMET and In Vitro Pharmacology
przibilla@pharmacelsus.de
Anika Christoffel
In Vivo Pharmacology & Pharmacokinetic
christoffel@pharmacelsus.de